Pmda - Pharmaceuticals and Medical Devices Agency
Menu
Close

Regulatory Science/The Science Board/Standard Development

The 1st Subcommittee on Cell and Gene Therapy Products Produced in vivo

Press Release

June 1, 2023 from10am to 12pm

Agenda / List of Handouts

Agenda
  1. Introduction of the Subcommittee Members
  2. Introduction of the Science Board
  3. Purpose and Work Schedule for the Subcommittee
    • Subcommittee on Cell and Gene Therapy Products Produced in vivo (Professor KUME, Chairperson of the Subcommittee)
  4. Lectures on Cell and Gene Therapy Products Produced in vivo
    • Development of hematopoietic stem cell gene therapy for sickle cell anemia(Dr. UCHIDA)
  5. Others
 
List of Handouts
  • Document 1 Member List of the Subcommittee
  • Document 2 Introduction of the Science Board
  • Document 3 Lecture Materials by Professor KUME, Chairperson of the Subcommittee
  • Document 4 Lecture Materials by Dr. UCHIDA
  • Ref.1 PMDA Science Board Rules
  • Ref.2 PMDA Science Board Subcommittee Rules
  • Ref.3 Rules for Commissioning Members of the Science Board and the Subcommittees
  • Ref.4 Memorandum of Understanding on Disclosure of Minutes and Handouts
  • Ref.5 Memorandum of Understanding for Requesting Attendance of External Experts
  • Ref.6 Memorandum of Understanding on Management of Working Group